サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/02/06 | 1,913.5 | 1,938.5 | 1,910 | 1,928 | +10.5 | +0.5% | 729,800 |
2025/02/05 | 1,900 | 1,917.5 | 1,893 | 1,917.5 | +4.5 | +0.2% | 718,400 |
2025/02/04 | 1,964 | 1,964 | 1,906 | 1,913 | -11 | -0.6% | 706,600 |
2025/02/03 | 1,991 | 1,995 | 1,914 | 1,924 | -87 | -4.3% | 1,122,300 |
2025/01/31 | 2,000 | 2,016 | 1,989 | 2,011 | +3.5 | +0.2% | 487,900 |
2025/01/30 | 2,004 | 2,026.5 | 1,998 | 2,007.5 | +3.5 | +0.2% | 442,200 |
2025/01/29 | 2,001 | 2,006 | 1,986.5 | 2,004 | ±0 | ±0% | 477,500 |
2025/01/28 | 2,034 | 2,040.5 | 1,996 | 2,004 | -27.5 | -1.4% | 605,200 |
2025/01/27 | 2,038.5 | 2,046 | 2,022 | 2,031.5 | +4.5 | +0.2% | 549,400 |
2025/01/24 | 2,038 | 2,044 | 2,019 | 2,027 | +13.5 | +0.7% | 764,700 |
2025/01/23 | 2,020 | 2,023.5 | 2,002 | 2,013.5 | -17 | -0.8% | 677,100 |
2025/01/22 | 2,036 | 2,051 | 2,020 | 2,030.5 | +5 | +0.2% | 591,200 |
2025/01/21 | 2,034 | 2,043 | 2,012 | 2,025.5 | +4.5 | +0.2% | 504,300 |
2025/01/20 | 2,015 | 2,031.5 | 2,002 | 2,021 | +6.5 | +0.3% | 647,100 |
2025/01/17 | 2,060 | 2,060 | 2,007 | 2,014.5 | -36 | -1.8% | 670,400 |
2025/01/16 | 2,128.5 | 2,143.5 | 2,038.5 | 2,050.5 | -59.5 | -2.8% | 941,700 |
2025/01/15 | 2,136.5 | 2,143.5 | 2,103 | 2,110 | -26.5 | -1.2% | 499,100 |
2025/01/14 | 2,180 | 2,183 | 2,114 | 2,136.5 | -48 | -2.2% | 881,100 |
2025/01/10 | 2,211 | 2,223 | 2,177.5 | 2,184.5 | -53 | -2.4% | 770,400 |
2025/01/09 | 2,187 | 2,250 | 2,176 | 2,237.5 | +112 | +5.3% | 1,149,700 |
2025/01/08 | 2,167.5 | 2,174 | 2,125.5 | 2,125.5 | -48.5 | -2.2% | 473,800 |
2025/01/07 | 2,132.5 | 2,199 | 2,130.5 | 2,174 | +30 | +1.4% | 657,900 |
2025/01/06 | 2,150 | 2,160.5 | 2,136.5 | 2,144 | -7 | -0.3% | 503,000 |
2024/12/30 | 2,170 | 2,181.5 | 2,151 | 2,151 | -12.5 | -0.6% | 364,500 |
2024/12/27 | 2,179 | 2,179 | 2,157.5 | 2,163.5 | +11.5 | +0.5% | 381,000 |
2024/12/26 | 2,159 | 2,166 | 2,129 | 2,152 | +13 | +0.6% | 363,900 |
2024/12/25 | 2,180 | 2,186.5 | 2,123 | 2,139 | -61.5 | -2.8% | 414,200 |
2024/12/24 | 2,175.5 | 2,234 | 2,162.5 | 2,200.5 | +20 | +0.9% | 774,000 |
2024/12/23 | 2,178.5 | 2,202 | 2,161.5 | 2,180.5 | +2 | +0.1% | 862,300 |
2024/12/20 | 2,090 | 2,193 | 2,090 | 2,178.5 | +128.5 | +6.3% | 1,216,500 |
2024/12/19 | 2,000 | 2,080 | 2,000 | 2,050 | +42 | +2.1% | 534,100 |
2024/12/18 | 2,020 | 2,039.5 | 1,998 | 2,008 | -17 | -0.8% | 505,700 |
2024/12/17 | 2,024.5 | 2,037 | 2,012.5 | 2,025 | -7.5 | -0.4% | 372,600 |
2024/12/16 | 2,039.5 | 2,039.5 | 2,001 | 2,032.5 | -9.5 | -0.5% | 559,500 |
2024/12/13 | 2,042.5 | 2,086.5 | 2,035 | 2,042 | -6.5 | -0.3% | 798,400 |
2024/12/12 | 2,056.5 | 2,063.5 | 2,030.5 | 2,048.5 | -2 | -0.1% | 638,800 |
2024/12/11 | 2,025.5 | 2,052.5 | 2,018.5 | 2,050.5 | +29.5 | +1.5% | 422,500 |
2024/12/10 | 2,079.5 | 2,080 | 2,009.5 | 2,021 | -31.5 | -1.5% | 509,400 |
2024/12/09 | 2,077 | 2,089.5 | 2,049 | 2,052.5 | -23.5 | -1.1% | 639,800 |
2024/12/06 | 2,114.5 | 2,131.5 | 2,074.5 | 2,076 | -56.5 | -2.6% | 738,700 |
2024/12/05 | 2,150 | 2,153 | 2,129 | 2,132.5 | -26 | -1.2% | 454,300 |
2024/12/04 | 2,190 | 2,200 | 2,146.5 | 2,158.5 | -14.5 | -0.7% | 556,000 |
2024/12/03 | 2,152.5 | 2,186 | 2,140 | 2,173 | +19 | +0.9% | 730,800 |
2024/12/02 | 2,156.5 | 2,159.5 | 2,137.5 | 2,154 | -20.5 | -0.9% | 673,300 |
2024/11/29 | 2,159 | 2,176 | 2,108 | 2,174.5 | -2 | -0.1% | 944,800 |
2024/11/28 | 2,064 | 2,197 | 2,055 | 2,176.5 | +124 | +6% | 1,399,800 |
2024/11/27 | 2,016.5 | 2,054 | 2,010 | 2,052.5 | +36 | +1.8% | 687,600 |
2024/11/26 | 1,987.5 | 2,016.5 | 1,966 | 2,016.5 | +29 | +1.5% | 707,700 |
2024/11/25 | 1,994 | 1,999 | 1,965.5 | 1,987.5 | +15.5 | +0.8% | 708,400 |
2024/11/22 | 1,950 | 1,984.5 | 1,938.5 | 1,972 | -2.5 | -0.1% | 714,000 |
101~
150
件表示中 / 1043件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 180,300円 | +5.9% | +684.6% | 3.05% | 11.96倍 | 1.19倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ツムラ | 350,900円 | +3.8% | -19.9% | 3.88% | 11.40倍 | 0.87倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 309,400円 | +8.0% | -15.3% | 4.01% | 8.69倍 | 0.84倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 152,900円 | +5.0% | +1.5% | 0.00% | 13.07倍 | 3.48倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 399,500円 | +3.6% | +6.1% | 3.00% | 13.46倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム